Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.670
+0.020 (1.21%)
At close: Feb 11, 2026, 4:00 PM EST
1.650
-0.020 (-1.20%)
After-hours: Feb 11, 2026, 4:10 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $5.22 million as of February 11, 2026. Its market cap has increased by 461.58% in one year.
Market Cap
5.22M
Enterprise Value
-2.06M
1-Year Change
461.58%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $5.22M, a decrease of -96.49%. That is a compound annual growth rate of -49.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 5.16M | -14.06% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 5.73M |
| BioRestorative Therapies | 5.50M |
| MetaVia | 5.45M |
| Processa Pharmaceuticals | 5.39M |
| 60 Degrees Pharmaceuticals | 5.28M |
| VivoSim Labs | 5.27M |
| Genprex | 5.10M |
| Decoy Therapeutics | 5.00M |